Explanatory Note
This Amendment No. 1 (this Amendment) amends and supplements the Schedule 13D filed on October 10, 2019 (the
Schedule 13D) by Benjamin J. Hindson (the Reporting Person) relating to the Class A Common Stock of 10x Genomics, Inc. (the Issuer). Information reported in the Schedule 13D remains in effect except to the
extent that it is amended, restated or superseded by information contained in this Amendment. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D. All references in the Schedule 13D and
this Amendment shall be deemed to refer to the Schedule 13D as amended and supplemented by this Amendment
Item 3.
|
Source and Amount of Funds or Other Consideration
|
Item 3 is amended and restated in its entirety to read as follows:
In connection with the founding of the Issuer, on July 12, 2012, the Reporting Person purchased 500 shares of Class B Common Stock
for an aggregate purchase price of $100.00. Pursuant to a 6,000-for-1 stock split effected September 26, 2012, the number of shares of Class B Common Stock
held by the Reporting Person increased to 3,000,000.
On October 27, 2015, the Issuer granted to the Reporting Person an option to
purchase 450,000 shares of Class A Common Stock at a per share exercise price of $0.88. Such option vested as to one-fourth of the shares on August 1, 2016 and
one-forty-eighth of the shares subject to the option vested each month thereafter. On various dates ranging from March 6, 2020 to March 12, 2021, the Reporting Person purchased an aggregate of
450,000 shares of Class A Common Stock upon the exercise of the option, for an aggregate purchase price of $396,000.00.
On
November 18, 2016, the Issuer granted to the Reporting Person an option to purchase 125,000 shares of Class A Common Stock at a per share exercise price of $1.07. Such option vested as to one-fourth
of the shares on August 1, 2017 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such
date. On various dates ranging from March 12, 2021 to May 3, 2021, the Reporting Person purchased an aggregate of 71,048 shares of Class A Common Stock upon the exercise of the option, for an aggregate purchase price of $76,021.36.
On October 18, 2017, the Issuer granted to the Reporting Person an option to purchase 200,000 shares of Class A Common Stock at
a per share exercise price of $1.20. Such option vested as to one-forty-eighth of the shares on October 1, 2017 and one-forty-eighth of the shares subject to the
option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. On various dates ranging from December 24, 2020 to July 1, 2021, the Reporting Person purchased an aggregate of
128,918 shares of Class A Common Stock upon the exercise of the option, for an aggregate purchase price of $154,701.60.
On
November 2, 2018, the Issuer granted to the Reporting Person an option to purchase 175,000 shares of Class A Common Stock at a per share exercise price of $5.04. Such option vested as to
one-forty-eighth of the shares on October 1, 2018 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting
Person continuing as a service provider through each such date.
On May 10, 2019, the Issuer granted to the Reporting Person an
option to purchase 100,000 shares of Class A Common Stock at a per share exercise price of $11.48. Such option vested as to one-forty-eighth of the shares on May 1, 2019 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
On April 21, 2020 the Issuer granted to the Reporting Person an option to purchase 136,000 shares of Class A Common Stock at a per
share exercise price of $74.58. Such option vested as to one-forty-eighth of the shares on May 1, 2020 and one-forty-eighth of the shares subject to the option vest
each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.